Literature DB >> 8322475

Giant fold gastritis--a special form of Helicobacter pylori associated gastritis.

M Stolte1, C Bätz, S Eidt.   

Abstract

We investigated the question as to how frequently Helicobacter pylori gastritis is present in cases of endoscopically detected giant folds of the corpus and fundic mucosa, and whether this gastritis differs from Helicobacter pylori associated gastritis with no giant folds. Biopsy material obtained from 138 patients with giant folds (sex ratio: 1.0 men: 105 women; average age 61.0 years) was evaluated histologically and compared with that obtained from 1,196 patients with H. pylori associated gastritis without giant folds (1.1 men: 1.0 women; average age 51.9 years). Among the patients with giant folds, H. pylori colonisation of the gastric mucosa was found in 88.4% of the cases. The degree of H. pylori colonisation determines the degree and activity of the gastritis in the antrum and corpus (p < 0.001). A comparison of the degree of colonisation with H. pylori, the degree of gastritis and the activity of the gastritis in patients with giant folds and in H. pylori gastritis without giant folds revealed no statistically significant differences within the antrum. In contrast, in the case of the corpus, a comparison between the two groups showed that H. pylori colonisation, degree of gastritis, and activity of gastritis were statistically significantly more pronounced in patients with giant folds than in patients with H. pylori gastritis but no giant folds (p < 0.0001). A comparative analysis showed that giant fold formation in the fundus and corpus of the stomach may be a consequence of severe high-grade active H. pylori gastritis, that is, a special and rare form of reaction to the colonisation of the gastric mucosa with Helicobacter pylori.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8322475

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  7 in total

1.  Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy.

Authors:  L G Madsen; M Taskiran; J L Madsen; P Bytzer
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis.

Authors:  Y Yasunaga; Y Shinomura; S Kanayama; Y Higashimoto; M Yabu; Y Miyazaki; S Kondo; Y Murayama; H Nishibayashi; S Kitamura; Y Matsuzawa
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

3.  A case of Ménétrier's disease localized to the gastric antrum without helicobacter infection or hypoalbuminemia.

Authors:  Adam R Sweeney; Maureen K Lynch
Journal:  Int J Surg Case Rep       Date:  2013-07-17

4.  Morphological and functional restoration of parietal cells in helicobacter pylori associated enlarged fold gastritis after eradication.

Authors:  Y Murayama; J Miyagawa; Y Shinomura; S Kanayama; Y Yasunaga; H Nishibayashi; K Yamamori; Y Higashimoto; Y Matsuzawa
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

5.  Protein-Losing Enteropathy Resolved by Helicobacter pylori Eradication.

Authors:  Bruno Sousa; Rosa Alves; Catarina Pestana Santos; Tiago Judas
Journal:  Eur J Case Rep Intern Med       Date:  2022-05-26

6.  A Case of H. pylori-associated Granulomatous Gastritis with Hypertrophic Gastropathy.

Authors:  Yeon Soo Kim; Hye Kyung Lee; Jong Ok Kim; Seung Woo Lee; Sang Beom Kang; Soon Woo Nam; Dong Soo Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

7.  Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis.

Authors:  Y Yasunaga; Y Shinomura; S Kanayama; M Yabu; T Nakanishi; Y Miyazaki; Y Murayama; J J Bonilla-Palacios; Y Matsuzawa
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.